GLP-1 drugs are reshaping consumer priorities, with appetite suppression driving demand for high-quality protein.
The study investigated the effects of A2 milk, marketed as a gut-friendly alternative, and protein-hydrolyzed lactose-free milk on gastrointestinal symptoms and inflammation levels.
A broad customer base and a track record of meeting production deadlines back this investment.